Finance

Lists
ATTO:NASDAQ
Attovia Therapeutics Inc
$19.86
+3.55%
(+0.68) 1D
Aug 14, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ATTO...
Open
$19.12
High
$19.94
Low
$18.20
Mkt. cap
854.56M
Avg. vol.
247.37K
Volume
98.16K
52-wk high
$22.79
52-wk low
$16.15
EPS
-$1.49
No. of employees
44
Open
$19.12
High
$19.94
Low
$18.20
Mkt. cap
854.56M
Avg. vol.
247.37K
Volume
98.16K
52-wk high
$22.79
52-wk low
$16.15
EPS
-$1.49
No. of employees
44
News stories
From web sources and news partners
About Attovia Therapeutics Inc
CEO-
Employees44
Founded2022
HeadquartersSan Carlos, California, United States
SectorBiotechnology
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reports
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Mar 2026
Revenue
-
-
Cost of goods sold
11.70M
16.51M
Cost of revenue
11.70M
16.51M
Research and development expenses
154.00K
239.00K
Total research and development expenses
-
-
Selling, general, and admin expenses
4.25M
3.21M
Operating expense
4.40M
3.45M
Total operating expenses
16.10M
19.96M
Operating income
-16.10M
-19.96M
Other non operating income
-173.00K
-27.00K
EBT including unusual items
-15.15M
-18.66M
EBT excluding unusual items
-15.15M
-18.66M
Income tax expense
-
-
Effective tax rate
-
-
Other operating expenses
-
-
Net income
-15.15M
-18.66M
Net profit margin
-
-
Earnings per share
-
-
Interest and investment income
1.13M
1.33M
Interest expense
-
-
Net interest expenses
1.13M
1.33M
Depreciation and amortization charges
-
-
EBITDA
-15.96M
-19.71M
Gain or loss from assets sale
6.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps